Baclofen/Naltrexone Hydrochloride/D-Sorbitol

巴氯芬/盐酸纳曲酮/山梨糖醇

Report date: 2026/05/12 20:00:17

Base Information

Drug NameBaclofen/Naltrexone Hydrochloride/D-Sorbitol
Drug Alias Name(RS)-baclofen/naltrexone/D-sorbitol盐酸纳曲酮/巴氯芬/山梨糖醇Naltrexone/sorbitol/baclofen盐酸纳曲酮/山梨糖醇/巴氯芬Naltrexone/baclofen/sorbitol +[12] 
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor antagonistsGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptorMu opioid receptor
Therapy Area/IndicationsCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes BaclofenNaltrexone HydrochlorideSorbitol
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesPharnext Sa
China Registration ClassN/A

Develop Information

Active CompaniesTasly GeneNet Pharmaceuticals Co LtdTasly Biomedical Co Ltd
Inactive CompaniesPharnext Quay Pharmaceuticals Ltd
Active IndicationsCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A